M&A

AI Collaborations – From Strategic License to Strategic Acquisition

Joshua Hofheimer

A Purchase-Price Adjustment Is Not the End of the Road With Indemnification on the Table

Robert S. Velevis

August Antitrust and Competition Bulletin: Top-of-Mind Global Antitrust Issues

Juan A. Arteaga

Avoiding Cross-Border Tax Traps: The Growing Importance of APAs

Dr. Idan Netser

Cashing Out: How Early Investors Can Cash Out and What It Means for the Company

Michael Podolny

Charles E. Santoro

Earnouts, AI, and Equitable Remedies: Delaware Court Reinstates CEO and Extends Payout Clock

Sharon Flanagan

Sally Wagner-Partin

Employee Classification Pitfalls

Engage Before You Mandate: When to Start Working With Bankers Pre-IPO

Engineering an Exit: M&A Preparedness for Private Companies

Alison M. Lehner

Getting Your House in Order: Corporate Housekeeping in Preparation for a Major Transaction

Navigating an Uncertain Market Amidst Cautious Optimism: Steps Biotech Companies Can Take to Hedge Against Financial Fluctuations

No Release Necessary: Delaware Court Draws a Line on Release Conditions in M&A

Peter J. Mardian

Barret V. Armbruster

Preserving ISO Status: What to Know Before Amending Option Awards

Public Benefit Corporation Directors not Obligated to get Best Price

Vincent J. Margiotta

Strategies for Early-Stage Biotech Companies

Strayed from the Path: Dodiya v. Franklin and the Emerging Rules of the DGCL’s Section 144 Safe Harbors

Arthur E. Adler

Timing Is Everything: Section 220 Standing After a Merger Closes

Matthew J. Dolan

What is a Greenshoe?

Rosemary Reilly

When AI Changes the Deal: Rethinking Risk, Milestones, and Timing in Life Sciences M&A

Sally Wagner-Partin

Sharon Flanagan

Whose Deal Is It Anyway? Conflicts of Interest and the Corporate Opportunity Doctrine in the Boardroom

Words Matter: Delaware Supreme Court Reinforces the Importance of Precision in Drafting ADR Provisions in Merger Agreements

Jaime A. Bartlett